Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial

The Lancet

Volumn 390, Issue 10109, 2017, Pages 2256-2265

  Lindholt, Jes S ^a,b   Søgaard, Rikke ^c  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b VIBORG HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTIC ANEURYSM; AGED; ALL CAUSE MORTALITY; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR SURGERY; COMORBIDITY; CONTROLLED STUDY; DANISH CITIZEN; DIABETES MELLITUS; FOLLOW UP; HAZARD RATIO; HUMAN; HYPERTENSION; INTERVENTION STUDY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MASS SCREENING; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; AGE; ANEURYSM RUPTURE; COMPARATIVE STUDY; DENMARK; ENDOVASCULAR SURGERY; INCIDENCE; MIDDLE AGED; MORTALITY; PROCEDURES; RISK ASSESSMENT; SURVIVAL RATE;

AGE FACTORS; AGED; ANEURYSM, RUPTURED; AORTIC ANEURYSM, ABDOMINAL; DENMARK; ENDOVASCULAR PROCEDURES; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RISK ASSESSMENT; SURVIVAL RATE;

EID: 85028398078     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)32250-X     Document Type: Article

References (31)

1. WHO. Cardiovascular disease. http://www.who.int/cardiovascular_diseases/en/ (accessed Aug 18, 2017).
2. Smith, SC Jr, Benjamin, EJ, Bonow, RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol 58 (2011), 2432–2446.
3. Wilson, J, Jungner, G, Principles and practice of screening for disease, 1968, World Health Organisation, Geneva.
4. Guirguis-Blake, JM, Beil, TL, Senger, CA, Whitlock, EP, Ultrasonography screening for abdominal aortic aneurysms: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 160 (2014), 321–329.
5. Jacomelli, J, Summers, L, Stevenson, A, Lees, T, Earnshaw, JJ, Impact of the first 5 years of a national abdominal aortic aneurysm screening programme. Br J Surg 103 (2016), 1125–1131.
6. Wanhainen, A, Hultgren, R, Linne, A, et al. Outcome of the Swedish nationwide abdominal aortic aneurysm screening program. Circulation 134 (2016), 1141–1148.
7. Sidloff, D, Stather, P, Dattani, N, et al. Aneurysm global epidemiology study: public health measures can further reduce abdominal aortic aneurysm mortality. Circulation 129 (2014), 747–753.
8. Lindholt, JS, Relatively high pulmonary and cardiovascular mortality rates in screening-detected aneurysmal patients without previous hospital admissions. Eur J Vasc Endovasc Surg 33 (2007), 94–99.
9. Alahdab, F, Wang, AT, Elraiyah, TA, et al. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg 61:suppl 3 (2015), 42S–53S.
10. Grondal, N, Sogaard, R, Henneberg, EW, Lindholt, JS, The Viborg Vascular (VIVA) screening trial of 65–74 year old men in the central region of Denmark: study protocol. Trials, 11, 2010, 67.
11. Grondal, N, Sogaard, R, Lindholt, JS, Baseline prevalence of abdominal aortic aneurysm, peripheral arterial disease and hypertension in men aged 65–74 years from a population screening study (VIVA trial). Br J Surg 102 (2015), 902–906.
12. Wittrup-Jensen, KU, Lauridsen, J, Gudex, C, Pedersen, KM, Generation of a Danish TTO value set for EQ-5D health states. Scand J Public Health 37 (2009), 459–466.
13. Lindholt, JS, Juul, S, Fasting, H, Henneberg, EW, Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ, 330, 2005, 750.
14. Thompson, SG, Ashton, HA, Gao, L, Buxton, MJ, Scott, RA, for the Multicentre Aneurysm Screening Study (MASS) Group. Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening. Br J Surg 99 (2012), 1649–1656.
15. Betteridge, DJ, Carmena, R, The diabetogenic action of statins—mechanisms and clinical implications. Nat Rev Endocrinol 12 (2016), 99–110.
16. Vidale, S, Antithrombotic drugs and risk of hemorrhagic stroke in the general population. Neurology, 82, 2014, 1193.
17. Carter, JL, Coletti, RJ, Harris, RP, Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ, 350, 2015, g7773.
18. Myers, ER, Moorman, P, Gierisch, JM, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA 314 (2015), 1615–1634.
19. Carter, SM, Rogers, W, Heath, I, Degeling, C, Doust, J, Barratt, A, The challenge of overdiagnosis begins with its definition. BMJ, 350, 2015, h869.
20. Johansson, M, Jorgensen, KJ, Brodersen, J, Harms of screening for abdominal aortic aneurysm: is there more to life than a 0·46% disease-specific mortality reduction?. Lancet 387 (2016), 308–310.
21. Orrapin, S, Rerkasem, K, Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev, 6, 2017 CD001081.
22. Burgess, C, Cornelius, V, Love, S, Graham, J, Richards, M, Ramirez, A, Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ, 330, 2005, 702.
23. The UK Small Aneurysm Trial Participants. Health service costs and quality of life for early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 352 (1998), 1656–1660.
24. Ashton, HA, Buxton, MJ, Day, NE, et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 360 (2002), 1531–1539.
25. Laustsen, J, Jensen, LP, Hansen, AK, for the Danish National Vascular Registry. Accuracy of clinical data in a population based vascular registry. Eur J Vasc Endovasc Surg 27 (2004), 216–219.
26. Lynge, E, Sandegaard, JL, Rebolj, M, The Danish National Patient Register. Scand J Public Health 39:suppl 7 (2011), 30–33.
27. Kildemoes, HW, Sorensen, HT, Hallas, J, The Danish National Prescription Registry. Scand J Public Health 39:suppl 7 (2011), 38–41.
28. GBD Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet 389 (2017), 1885–1906.
29. Lindholt, JS, Heickendorff, L, Vammen, S, Fasting, H, Henneberg, EW, Five-year results of elastin and collagen markers as predictive tools in the management of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 21 (2001), 235–240.
30. Lindholt, JS, Juul, S, Fasting, H, Henneberg, EW, Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ, 330, 2005, 750.
31. Jorgensen, T, Jacobsen, RK, Toft, U, Aadahl, M, Glumer, C, Pisinger, C, Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ, 348, 2014, g3617.